MedTrace Logo

A Comparison Between TOF Watch® SX and Tetragraph®

NCT04947306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-07-01

No results posted yet for this study

Summary

This observational study was designed to assess the agreement between the recently marketed electromyographic neuromuscular blockade monitor Tetragraph® (Senzime, Uppsala, Sweden) and the TOF Watch® SX (Organon Teknika B.V., Boxtel, Holland), an accelerometric neuromuscular blockade monitor frequently used in clinical practice

Conditions

  • Neuromuscular Blockade
  • Neuromuscular Monitoring

Interventions

DEVICE

Tetragraph® (Senzime, Uppsala, Sweden)

The Tetragraph® is a recently marketed electromyographic neuromuscular monitor that uses a disposable electrode array (TetraSens) that combines stimulating and recording electrodes

DEVICE

TOF Watch® SX (Organon Teknika B.V., Boxtel, Holland)

The TOF Watch® SX is a common used neuromuscular monitor

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-24
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04947306 on ClinicalTrials.gov